-
REAL-WORLD SURVIVAL OUTCOMES IN KRAS(G12C) METASTATIC COLORECTAL CANCER IN THE UNITED STATES AND CANADA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
EVALUATING THE ECONOMIC VALUE OF MONOCLONAL ANTIBODIES FOR AQP4+ NMOSD IN THE US USING ATTACK-FREE SURVIVAL OVER A 5-YEAR HORIZON
Mar 18, 2026, 21:38 PM -
INCORPORATING REAL-WORLD EVIDENCE INTO TIME-TO-EVENT EXTRAPOLATIONS FROM CLINICAL TRIAL DATA
Mar 18, 2026, 21:38 PM -
EXPLORING THE OPTIMAL SHARE OF PHARMACEUTICAL VALUE FOR INDUSTRY AND SOCIETY: AN APPLICATION TO THE US CONTEXT
Mar 18, 2026, 21:38 PM -
LEVERAGING INVERSE PROBABILITY WEIGHTING TO ADDRESS TIME-DEPENDENT BIAS INTRODUCED BY NONRESPONSE IN REAL-WORLD LONGITUDINAL RESEARCH INVOLVING PATIENT-REPORTED OUTCOME MEASURES
Mar 18, 2026, 21:38 PM -
PATTERNS AND PREDICTORS OF ANTIDEPRESSANT USE AMONG ADULTS WITH DEPRESSION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD UTILIZATION AND TREATMENT ADHERENCE OF BRAND AND GENERIC CYCLOSPORINE OPHTHALMIC EMULSION IN DRY EYE DISEASE
Mar 18, 2026, 21:38 PM -
REAL-WORLD OUTCOMES OF MECHANICAL, PORCINE, AND DURABLE VALVES IN SEVERE AORTIC STENOSIS: SURVIVAL, REINTERVENTION, AND EARLY MORTALITY ANALYSIS
Mar 18, 2026, 21:38 PM -
TITLE: COST-UTILITY ANALYSIS OF CALCITONIN GENE-RELATED PEPTIDE ANTIBODIES FOR PATIENTS WITH CHRONIC MIGRAINE: A UNITED STATES PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
INFLATION REDUCTION ACT “PILL PENALTY” AND SMALL-MOLECULE INNOVATION: SIGNALS FROM INVESTMENT, PIPELINES, AND POST-APPROVAL RESEARCH?
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGICAL CHARACTERISTICS OF DIABETIC KIDNEY DISEASE IN CHINESE PATIENTS WITH TYPE 2 DIABETES VISITING A TERTIARY CARE HOSPITAL: A RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND CLINICAL PROGRESSION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM: A REAL-WORLD STUDY (2012-2024)
Mar 18, 2026, 21:38 PM -
COMPARISON OF THE PERFORMANCE OF PATIENT-MEDIATED MEDICAL RECORD RETRIEVAL AND TOKENIZATION-BASED LINKAGE TO GENERATE COMPLETE AND LONGITUDINAL REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT MODEL (BIM) OF BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE (BVD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE UNITED STATES (US)
Mar 18, 2026, 21:38 PM -
LONG-TERM PROJECTIONS OF PEDIATRIC IMMUNE THROMBOCYTOPENIA BURDEN IN THE UNITED STATES: EPIDEMIOLOGIC INSIGHTS FROM 2025 TO 2050
Mar 18, 2026, 21:38 PM -
CLAIMS-BASED ALGORITHM OPTIONS TO IDENTIFY REDUCED LEFT VENTRICULAR EJECTION FRACTION PATIENTS WITH MITRAL OR TRICUSPID VALVE REGURGITATION AND HEART FAILURE
Mar 18, 2026, 21:38 PM -
PERFORMANCE METRICS FOR AI IN SLRS: A RAPID LITERATURE REVIEW OF GUIDELINE RECOMMENDATIONS FOR ACCEPTABLE THRESHOLDS
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND MACHINE LEARNING PREDICTORS OF LATER-LINE THERAPY IN METASTATIC COLORECTAL CANCER
Mar 18, 2026, 21:38 PM -
NOVEL THERAPIES FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA POST BRUTON’S TYROSINE KINASE INHIBITOR: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
HEALTH CARE RESOURCE USE IN RARE DISEASE CLINICAL TRIALS: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM
